Dutta

Pacvue Accelerates Growth with New Key Hires

Retrieved on: 
Wednesday, December 20, 2023

LOS ANGELES, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Pacvue , the industry’s first commerce acceleration platform, today announced it is strengthening its leadership team with several new hires across departments to ramp innovation and growth.

Key Points: 
  • LOS ANGELES, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Pacvue , the industry’s first commerce acceleration platform, today announced it is strengthening its leadership team with several new hires across departments to ramp innovation and growth.
  • Pacvue is undergoing tremendous growth to keep up with brands’ increased investment in commerce and retail media.
  • Most recently, Amazon selected Pacvue as one of its beta partners for its new AI-powered image generator tool.
  • Additionally, the company introduced several new solutions and tools including Pacvue XL Copilot, with more AI-enhanced products set to launch in 2024.

Accenture Announces Leadership Appointments in India

Retrieved on: 
Friday, May 5, 2023

Accenture (NYSE: ACN) has announced new appointments to its leadership team in India.

Key Points: 
  • Accenture (NYSE: ACN) has announced new appointments to its leadership team in India.
  • The company also announced that Rekha M. Menon, Senior Managing Director and Chairperson for Accenture in India, will retire as of June 30.
  • As country managing director, Ajay Vij will expand his current responsibilities as the Corporate Services & Sustainability lead for India to provide overall leadership and drive coordinated decision-making for key company priorities.
  • Sandeep Dutta, the India Sales Lead will now lead Accenture’s India Market Unit, serving as our India business lead responsible for driving business and operations in the domestic market, focusing on growth, market differentiation, and clients.

EY US report: A majority of supply chain executives are focused on ESG but lack capabilities to measure supply chain sustainability

Retrieved on: 
Thursday, September 22, 2022

The EY 2022 Supply Chain Sustainability Report surveyed 525 senior supply chain executives from large organizations across North, Central and South America and found that despite having articulated a long-term vision, 33% lack a business case to support sustainable supply chain development.

Key Points: 
  • The EY 2022 Supply Chain Sustainability Report surveyed 525 senior supply chain executives from large organizations across North, Central and South America and found that despite having articulated a long-term vision, 33% lack a business case to support sustainable supply chain development.
  • Additionally, nearly 1 in 5 do not have a sustainability strategy or know where to begin, and half of the executives don't have an integrated scorecard to measure supply chain sustainability results.
  • The report outlines five recommendations for leaders to jump-start their supply chain sustainability programs:
    Estimate the gap with goals: Understand current sustainability performance and examine how the current supply chain design supports (or does not support) the organization-wide sustainability commitments and goals.
  • "Cost savings is not the only benefit supply chain leaders should expect from sustainability initiatives," said Sumit Dutta, EY Americas Supply Chain and Operations Markets Leader.

iBio Provides Update on Development of Next-Gen COVID-19 Vaccine Candidate

Retrieved on: 
Tuesday, August 16, 2022

BRYAN, Texas, Aug. 16, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable FastPharming® Manufacturing System, today provided an update on IBIO-202, its next-generation vaccine candidate under development for multi-variant COVID-19 disease.

Key Points: 
  • BRYAN, Texas, Aug. 16, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (iBio or the Company), a developer of next-generation biopharmaceuticals and pioneer of the sustainable FastPharming Manufacturing System, today provided an update on IBIO-202, its next-generation vaccine candidate under development for multi-variant COVID-19 disease.
  • In November 2020, iBio began exploring a second-generation COVID-19 vaccine program based on the N protein.
  • 2 Dutta, N. K., Mazumdar, K. & Gordy, J. T. The Nucleocapsid Protein of SARSCoV-2: A Target for Vaccine Development.
  • The Companys wholly-owned subsidiary, iBio CDMO LLC, provides FastPharming Contract Development and Manufacturing Services along with Glycaneering Development Services for advanced recombinant protein design.

Fidelity Investments® Launches Innovative Benefits Equity℠ Scorecard to Help Organizations Ensure Employee Benefits Are Equitable and Inclusive for All Workers

Retrieved on: 
Thursday, March 3, 2022

Traditionally, employee benefits have been designed to meet the needs of a broad majority, which can leave some workers feeling excluded.

Key Points: 
  • Traditionally, employee benefits have been designed to meet the needs of a broad majority, which can leave some workers feeling excluded.
  • The Benefits Equity assessment and scorecard provide employers with the insight they need to help their benefits become more equitable.
  • Fidelity's Benefits Equity assessment and scorecard are part of a unique, holistic approach that evaluates an organizations complete benefits portfolio.
  • For additional information on Fidelity's Benefits Equity Scorecard, please click here for details on upcoming webinars or visit www.fidelityworkplace.com/s/workplaceconsulting .